The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Self-citationP‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins
Juranka, P. F., Zastawny, R. L., & Ling, V. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.14.2574119 · Cited by 503
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Pusztai, L., Wagner, P., Ibrahim, N., Rivera, E., Theriault, R., Booser, D., Symmans, F. W., Wong, F., Blumenschein, G., Fleming, D. R., et al. (2005) · Cancer · doi:10.1002/cncr.21227 · Cited by 302
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
O’Donovan, T. R., O’Sullivan, G. C., & McKenna, S. L. (2011) · Autophagy · doi:10.4161/auto.7.5.15066 · Cited by 279
Drug resistance: Still a daunting challenge to the successful treatment of AML
Shaffer, B. C., Gillet, J.-P., Patel, C., Baer, M. R., Bates, S. E., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.02.001 · Cited by 259
MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine
Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M., & Fromm, M. F. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01591.x · Cited by 249
Cheng, W., Liu, T., Wan, X., Gao, Y., & Wang, H. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08589.x · Cited by 229
Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer
Liu, L., Ning, X., Sun, L., Zhang, H., Shi, Y., Guo, C., Han, S., Liu, J., Sun, S., Han, Z., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00643.x · Cited by 226
Self-citationHistone deacetylase 10 promotes autophagy-mediated cell survival
Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221 · cited 1×
“oncogene, neuroblastoma derived)-amplified neuroblastoma cell lines, in contrast to nontransformed cells [31].”
BackgroundClinical applications of the histoculture drug response assay.
Furukawa, T., Kubota, T., & Hoffman, R. M. (1995) · PubMed · Cited by 217
Sarvi, S., Mackinnon, A. C., Avlonitis, N., Bradley, M., Rintoul, R. C., Rassl, D. M., Wang, W., Forbes, S. J., Gregory, C. D., & Sethi, T. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1541 · Cited by 208
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
Shang, Y., Zhang, Z., Liu, Z., Feng, B., Ren, G., Li, K., Zhou, L., Sun, Y., Li, M., Zhou, J., et al. (2014) · Oncogene · doi:10.1038/onc.2013.297 · Cited by 188
Self-citationKannan, P., Telu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Halldin, C., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100078a · Cited by 181
MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
Wang, F., Li, T., Zhang, B., Li, H., Wu, Q., Yang, L., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.010 · Cited by 170
Self-citationPhytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance
Balachandran, V., Maliekal, T. T., & Anto, R. J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4573 · Cited by 145
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration
Lee, E., Kim, H., Lee, I., & Jon, S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.014 · Cited by 144
Zhang, L., Pickard, K. M., Jenei, V., Bullock, M. D., Bruce, A., Mitter, R., Kelly, G. P., Paraskeva, C., Strefford, J., Primrose, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3308 · Cited by 142
Agrawal, M., Abraham, J., Balis, F. M., Edgerly, M., Stein, W. D., Bates, S. E., Fojo, T., & Chen, C. C. (2003) · PubMed · Cited by 135
Martín, V., Sánchez‐Sánchez, A. M., Herrera, F., Gomez‐Manzano, C., Fueyo-Margareto, J., Vega, M. A. Á., Antolín, I., & Rodríguez, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.188 · Cited by 133
Stewart, A. J., Steiner, J., MELLOWS, G., Laguda, B., Norris, D., & Bevan, P. (2000) · PubMed · Cited by 122
Chen, Z., Ma, T., Huang, C. Z., Zhang, L., Lv, X., Xu, T., Hu, T., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.032 · Cited by 122
A high content screening assay to predict human drug-induced liver injury during drug discovery
Persson, M., Løye, A. F., Mow, T. J., & Hornberg, J. J. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.08.001 · Cited by 120
Eid, S. Y., El-Readi, M. Z., & Wink, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.08.010 · Cited by 116
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Ivanova, T., Zouridis, H., Wu, Y., Cheng, L. L., Tan, I. B., Gopalakrishnan, V., Ooi, C.-H., Lee, J., Qin, L., Wu, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301113 · Cited by 114
Du, J.-P., Pan, Y., Shi, Y., Guo, C., Jin, X., Sun, L. J., Liu, N., Qiao, T., & Fan, D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20570 · Cited by 104
Self-citationInhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals
Nabekura, T., Yamaki, T., Hiroi, T., Ueno, K., & Kitagawa, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.010 · Cited by 101
Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
Chen, Q., Xia, H., Ge, X.-J., Zhang, Y., Tang, Q., & Bi, F. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7421 · Cited by 99
Multidrug resistance in ovarian cancer
Fojo, A. T., Hamilton, T. C., Young, R. C., & Ozols, R. F. (1987) · Cancer · Cited by 93
Lebedeva, I. V., Pande, P., & Patton, W. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022429 · Cited by 88
Li, X., Dong, Y., Wang, W., Wang, H., Chen, Y., Shi, G., Yi, J., & Wang, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0709 · Cited by 78
Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line
Xue, Z., Yan, H. M., Li, J., Liang, S., Cai, X., Chen, X., Wu, Q., Gao, L., Wu, K., Nie, Y., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23356 · Cited by 75
Self-citationTaipalensuu, J., Tavelin, S., Lazorova, L., Svensson, A.-C., & Artursson, P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00204-5 · Cited by 71
Sun, J., Yeung, C. A., Co, N. N., Tsang, T. Y., Yau, E., Luo, K.-W., Wu, P., Chan, J. Y., Fung, K., Kwok, T. T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040720 · Cited by 69
Kang, J., Zhao, G., Lin, T., Tang, S., Xu, G., Hu, S., Bi, Q., Guo, C., Sun, L., Han, S., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.016 · Cited by 68
Self-citationMetnase mediates chromosome decatenation in acute leukemia cells
Wray, J. W., Williamson, E. A., Sheema, S., Lee, S., Libby, E. N., Willman, C. L., Nickoloff, J. A., & Hromas, R. (2009) · Blood · doi:10.1182/blood-2008-08-175760 · Cited by 67
Lincke, C. R., Broeks, A., The, I., Plasterk, R. H. A., & Borst, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05806.x · Cited by 65
Digitonin synergistically enhances the cytotoxicity of plant secondary metabolites in cancer cells
Eid, S. Y., El-Readi, M. Z., & Wink, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.09.002 · Cited by 62
Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells
Wray, J. W., Williamson, E. A., Royce, M., Shaheen, M. F., Beck, B. D., Lee, S., Nickoloff, J. A., & Hromas, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005323 · Cited by 54
Liu, L., Sun, L., Zhang, H., Li, Z., Ning, X., Shi, Y., Guo, C., Han, S., Wu, K., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.24135 · Cited by 52
Self-citationThe right drug for the right patient.
Klett, C. J., & Moseley, E. C. (1965) · Journal of Consulting Psychology · doi:10.1037/h0022770 · Cited by 51
Casorelli, I., Bossa, C., & Bignami, M. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9082636 · Cited by 47
Azab, F., Vali, S., Abraham, J., Potter, N. A., Muz, B., de la Puente, P., Fiala, M. A., Paasch, J., Sultana, Z., Tyagi, A., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12734 · Cited by 45
Zhao, L., Pan, Y., Yi, G., Wang, H., Jin, H., Tie, J., Xia, L., Zhang, Y., He, L., Yao, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028068 · Cited by 45
Self-citationProstate cancer invasion and metastasis: insights from mining genomic data
Hudson, B. D., Kulp, K. S., & Loots, G. G. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt021 · Cited by 43
Liang, B., Kong, D., Liu, Y., Liang, N., He, M., Ma, S., & Liu, X. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-213 · Cited by 43
Hai-ya, H., Niu, J., Zhao, L., & Lü, Y. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.04.001 · Cited by 39
Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy
Williamson, E. A., Damiani, L. A., Leitão, A., Hu, C., Hathaway, H. J., Oprea, T. I., Sklar, L. A., Shaheen, M. F., Bauman, J. E., Wang, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0313 · Cited by 39
Guo, X., Hu, F., Zhang, S., Zhao, Q., Zong, C., Ye, F., Guo, S., Zhang, J., Li, R., Wu, M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.011 · Cited by 37
Park, S., Wang, X., Liu, R., Lam, K. S., & Weiss, R. H. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7069 · Cited by 36
Optimization of Novel Indole-2-carboxamide Inhibitors of Neurotropic Alphavirus Replication
Sindac, J. A., Barraza, S. J., Dobry, C. J., Xiang, J., Blakely, P. K., Irani, D. N., Keep, R. F., Miller, D. J., & Larsen, S. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401330r · Cited by 33
Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
Xu, C.-Z., Xie, J., Jin, B., Chen, X., Sun, Z., Wang, B.-X., & Dong, P. (2013) · Europe PMC (PubMed Central) · Cited by 30
In-depth research of multidrug resistance related cell surface glycoproteome in gastric cancer
Li, K., Sun, Z., Zheng, J., Lu, Y., Bian, Y., Ye, M., Wang, X., Nie, Y., Zou, H., & Fan, D. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.021 · Cited by 30
Self-citationYin, F. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v6.i5.664 · Cited by 27
Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment
Iangcharoen, P., Punfa, W., Yodkeeree, S., Kasinrerk, W., Ampasavate, C., Anuchapreeda, S., & Limtrakul, P. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1012-4 · Cited by 27
Langer, R., Ott, K., Feith, M., Lordick, F., Specht, K., Becker, K., & Höfler, H. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21641 · Cited by 25
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line
Lu, J., Chen, S.-M., Ding, J., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1072-2 · Cited by 24
Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells
Liu, L., Ning, X., Sun, L., Shi, Y., Han, S., Guo, C., Chen, Y., Sun, S., Yin, F., Wu, K., et al. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9467-9 · Cited by 24
Self-citationHigh Content Screening with Primary Neurons
Al‐Ali, H., Blackmore, M. G., Bixby, J. L., & Lemmon, V. (2014) · Cited by 24
A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma
Shao, S., Huang, X., Wang, Y., He, S., Xu, X., Zhu, X., Yang, X., Ding, Z., Li, Y., Huang, Y., et al. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1484-8 · Cited by 19
Liu, X., Qiao, L., Xie, D., et al. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.09.001 · Cited by 15
High Content Screening as High Quality Assay for Biological Evaluation of Photosensitizers In Vitro
Vaz, G. M. F., Paszko, E., Davies, A. M., & Senge, M. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070653 · Cited by 14
“Right Drug for the Right Patient”: Hurdles and the Path Forward in Colorectal Cancer
Kopetz, S. (2013) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbook_am.2013.33.e115 · Cited by 10
Mamidipudi, V., Shi, T., Brady, H. A., Surapaneni, S., Chopra, R., Aukerman, S. L., Heise, C. C., & Sung, V. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1782-x · Cited by 8
Rosania, G. R., Shedden, K., Zheng, N., & Zhang, X. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-44 · Cited by 7
Schmandke, A., Schmandke, A., Pietro, M. A., & Schwab, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078212 · Cited by 7
Zhou, F., Mei, H., Wu, Q., & Jin, R. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0242-5 · Cited by 6
Self-citation
Cited by
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Metadata
- Authors
- Wu, Q., Yang, Z., Nie, Y., Shi, Y., & Fan, D.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 347
- Issue
- 2
- Pages
- 159-166
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2020224261
- Cited by
- 776
- References
- 71
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.